CSIMarket Company Name, Ticker, Industry, else..
 
Third Harmonic Bio Inc   (NASDAQ: THRD)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 45
 Employees 53
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 53
 Cash Flow (TTM) (Millions $) 9
 Capital Exp. (TTM) (Millions $) 0

Business Description


Third Harmonic Bio Inc is a biotechnology company that specializes in the development of immunotherapies for cancer treatment. The company focuses on leveraging the power of the immune system to target and destroy cancer cells. Their innovative approach involves the use of proprietary technology to harness the immune system's natural ability to recognize and eliminate cancerous cells. Third Harmonic Bio Inc is committed to advancing the field of cancer immunotherapy and improving patient outcomes.


   Company Address: 1700 Montgomery Street San Francisco 94111 CA
   Company Phone Number: 727-2457   Stock Exchange / Ticker: NASDAQ THRD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABBV        5.73% 
BMY   -1.48%    
JNJ   -0.71%    
MRK   -3.15%    
PFE   -0.86%    
TAK        2.07% 
• View Complete Report
   



Clinical Study

Navigating Liquidation Third Harmonic Bios Strategic Exit and Financial Resilience

Published Thu, Jun 12 2025 12:47 PM UTC

Abstract Third Harmonic Bio Inc. (THB) has recently undergone significant corporate transformations, including stockholder-approved liquidation and dissolution. Meanwhile, financial ratios reveal a dynamic yet challenging fiscal environment. This article explores the implications of these developments for the company and its stakeholders, providing insight into its perform...
Clinical Study

Analyzing Third Harmonic Bios Financial Performance and Strategic Engagement in the Biopharmaceutical Sector

Published Mon, Aug 26 2024 8:00 PM UTC

In the rapidly evolving field of biopharmaceuticals, companies must navigate various challenges, from financial performance to investor relations. Third Harmonic Bio, Inc. (Nasdaq: THRD) stands out as a clinical-stage company dedicated to addressing inflammatory diseases affecting the dermal, respiratory, and gastrointestinal systems. Recent developments surrounding the comp...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 53.24
Working Capital Ratio 54.1
Leverage Ratio (MRQ) 0.03
Total Debt to Equity -
Interest Coverage (TTM) 5.16
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 1.77 $
Revenues (TTM) -
Cash Flow (TTM) 0.2 $
Cash 6.05 $
Book Value 6.07 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) 1,008,434
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) 18.86 %
Return On Investment (TTM) 19.1 %
Return On Equity (TTM) 19.27 %
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.